Cerebrovascular disease in type 2 diabetes

Laakso, 1996, Insulin resistance and coronary heart disease, Curr. Opin. Lipidol., 7, 217, 10.1097/00041433-199608000-00008 Pyörälä, 1987, Diabetes and atherosclerosis: an epidemiologic view, Diabetes/Metabolism Rev., 3, 463, 10.1002/dmr.5610030206 Baker, 1963, Cerebrovascular disease: VIII. Role of nutritional factors, Neurology, 13, 486 Grunnet, 1963, Cerebrovascular: diabetes and cerebral atherosclerosis, Neurology, 13, 486, 10.1212/WNL.13.6.486 Idris, 2006, Diabetes mellitus and stroke, Int. J. Clin. Pract., 60, 48, 10.1111/j.1368-5031.2006.00682.x You, 1997, Risk factors for stroke due to cerebral infarction in young adults, Stroke, 28, 1913, 10.1161/01.STR.28.10.1913 Hankey, 1998, Long-term risk of first recurrent stroke in the Perth Community Stroke Study, Stroke, 29, 2491, 10.1161/01.STR.29.12.2491 Tuomilehto, 1996, Diabetes mellitus as a risk factor for death from stroke, Stroke, 27, 210, 10.1161/01.STR.27.2.210 Luchsinger, 2001, Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort, Am. J. Epidemiol., 154, 635, 10.1093/aje/154.7.635 Folsom, 1999, Prospective associations of fasting insulin, body fat distribution, and diabetes with risk of ischemic stroke, Diabetes Care, 22, 1077, 10.2337/diacare.22.7.1077 Sacco, 2001, High-density lipoprotein cholesterol and ischemic stroke in patients with diagnosed with TIA, Neurology, 28, 280 Pyörälä, 2000, Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study, Arterioscler. Thromb. Vasc. Biol., 20, 538, 10.1161/01.ATV.20.2.538 Salmenniemi, 2004, Multiple abnormalities in glucose and energy metabolism, and coordinated changes in levels of adiponectin, cytokines and adhesion molecules in subjects with the metabolic syndrome, Circulation, 110, 3842, 10.1161/01.CIR.0000150391.38660.9B Kuusisto, 1994, Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects, Stroke, 25, 1157, 10.1161/01.STR.25.6.1157 Beckman, 2002, Diabetes and atherosclerosis. Epidemiology, pathophysiology, and management, JAMA, 287, 2570, 10.1001/jama.287.19.2570 Vinik, 2001, Platelet dysfunction in type 2 diabetes, Diabetes Care, 24, 1476, 10.2337/diacare.24.8.1476 Stevens, 2004, Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes. UKPDS 66, Diabetes Care, 27, 201, 10.2337/diacare.27.1.201 Lehto, 1996, Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes, Stroke, 27, 63, 10.1161/01.STR.27.1.63 Miettinen, 1996, Proteinuria predicts stroke and other atherosclerotic vascular disease events in nondiabetic and non-insulin-dependent diabetic subjects, Stroke, 27, 2033, 10.1161/01.STR.27.11.2033 Davis, 1999, Risk factors for stroke in type 2 diabetes mellitus. United Kingdom Prospective Diabetes Study (UKPDS) 29, Arch. Intern. Med., 159, 1097, 10.1001/archinte.159.10.1097 Sowers, 2004, Treatment of hypertension in patients with diabetes, Arch. Intern. Med., 164, 1850, 10.1001/archinte.164.17.1850 2005, Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins, Lancet, 366, 1267, 10.1016/S0140-6736(05)67394-1 Stettler, 2006, Glycemic control and macrovascular disease in type 1 and 2 diabetes mellitus: meta-analysis of randomized trials, Am. Heart. J., 152, 27, 10.1016/j.ahj.2005.09.015 Dormandy, 2005, Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial, Lancet, 366, 1279, 10.1016/S0140-6736(05)67528-9 Coldwell, 2004, Aspirin therapy in diabetes, Diabetes Care, S72